Medical Design Technology -
9 May 2019 16:00
News Currently, there are no disease-modifying therapies for the treatment of Parkinson's disease; however, one potential strategy for treatment is to prevent α-synuclein aggregation... Contributed Author: Osaka University Topics: Neurology
Share this Article